Maria Finch, NP
Nurse Practitioner · Wilmington, NCNPI 1376916296
Payments from drug & device makers
Across 437 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- AstraZeneca$1K
- GSK$1K
- Philips North America LLC$521
- Regeneron Healthcare Solutions, Inc.$519
- Sanofi$370
- plus $3K from 34 others
What the payments were for
- Food & beverage$8,45799%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 72 | $1,652 |
| AstraZeneca | 59 | $1,300 |
| GSK | 84 | $1,092 |
| Philips North America LLC | 34 | $521 |
| Regeneron Healthcare Solutions, Inc. | 24 | $519 |
| Sanofi | 19 | $370 |
| Insmed, Inc. | 18 | $298 |
| Jazz Pharmaceuticals Inc. | 11 | $289 |
| United Therapeutics Corporation | 11 | $284 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $268 |
| Merck | 10 | $236 |
| Mylan Specialty L.p. | 9 | $177 |
| Teva Pharmaceuticals USA, Inc. | 7 | $120 |
| ANI Pharmaceuticals, Inc. | 6 | $107 |
| Grifols USA, LLC | 5 | $97 |
| Electromed, Inc. | 5 | $95 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $93 |
| Harmony Biosciences LLC | 5 | $90 |
| Actelion Pharmaceuticals US, Inc. | 3 | $85 |
| Sanofi-aventis U.S. LLC | 2 | $82 |
| Baxter Healthcare | 2 | $78 |
| Amgen | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Viatris Specialty LLC | 3 | $56 |
| Vifor Pharma, Inc. | 3 | $56 |
| Verona Pharma, Inc. | 3 | $55 |
| Pfizer | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $35 |
| Inogen, Inc. | 2 | $33 |
| Resmed Corp | 1 | $31 |
| Stryker | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Gilead | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,516 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 842 | $671,192 |
| GlassiaAlpha-1-Proteinase Inhibitor | 28 | $310,788 |
| OfevNintedanib Esylate | 23 | $302,817 |
| ZemairaAlpha-1-Proteinase Inhibitor | 14 | $136,991 |
| Breo ElliptaFluticasone/Vilanterol | 196 | $108,851 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 146 | $108,240 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 170 | $106,758 |
| Dupixent PenDupilumab | 17 | $65,531 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 119 | $60,368 |
| Spiriva RespimatTiotropium Bromide | 58 | $38,555 |
| SymbicortBudesonide/Formoterol Fumarate | 85 | $29,565 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 554 | $15,665 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 55 | $10,114 |
| Wixela InhubFluticasone Propion/Salmeterol | 51 | $9,176 |
| Arnuity ElliptaFluticasone Furoate | 19 | $8,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta | $1,092 | $903,4481,250 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $1,652 | $401,740200 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Glassia | $268 | $310,78828 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,300 | $143,908247 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Wilmington
- Bridgette WilliamsWilmington$35K
- Kelly GlissonWilmington$30K
- Lauren GardnerWilmington$28K
- Michelle StoughWilmington$24K
- Edith SaffoWilmington$19K
- Rebecca MaphisWilmington$18K
- Breanna BrousseauWilmington$12K
- Anna PaylorWilmington$11K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.